These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19460505)

  • 1. Evaluation of serum sCD30 in renal transplantation patients with and without acute rejection.
    Cervelli C; Fontecchio G; Scimitarra M; Azzarone R; Famulari A; Pisani F; Battistoni C; Di Iulio B; Fracassi D; Scarnecchia MA; Papola F
    Transplant Proc; 2009 May; 41(4):1159-61. PubMed ID: 19460505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
    Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
    Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection.
    Nafar M; Farrokhi F; Vaezi M; Entezari AE; Pour-Reza-Gholi F; Firoozan A; Eniollahi B
    Int Urol Nephrol; 2009; 41(3):687-93. PubMed ID: 19142743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30.
    Süsal C; Pelzl S; Döhler B; Opelz G
    J Am Soc Nephrol; 2002 Jun; 13(6):1650-6. PubMed ID: 12039995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined assay of soluble CD30 and hepatocyte growth factor for diagnosis of acute renal allograft rejection].
    Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; Du CF; Wang YB
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):241-2. PubMed ID: 18250052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD30 as a predictor of kidney graft outcome.
    Pelzl S; Opelz G; Wiesel M; Schnülle P; Schönemann C; Döhler B; Süsal C
    Transplantation; 2002 Jan; 73(1):3-6. PubMed ID: 11792970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S; Keven K; Gormez U; Kutlay S; Erturk S; Erbay B
    Transplantation; 2006 Apr; 81(8):1216-9. PubMed ID: 16641611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts.
    Karahan GE; Caliskan Y; Ozdilli K; Kekik C; Bakkaloglu H; Caliskan B; Turkmen A; Sever MS; Oguz FS
    Int J Artif Organs; 2017 Jan; 39(11):547-552. PubMed ID: 28058698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
    Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection.
    Saini D; Ramachandran S; Nataraju A; Benshoff N; Liu W; Desai N; Chapman W; Mohanakumar T
    Am J Transplant; 2008 Sep; 8(9):1798-808. PubMed ID: 18786226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N; Aghdaie MH; Malekpour Z
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
    Hamer R; Roche L; Smillie D; Harmer A; Mitchell D; Molostvov G; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Briggs D; Lowe D; Zehnder D; Higgins R
    Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure?
    de Holanda MI; Matuck T; de Carvalho DDBM; Domingues EMFL; Curvo R; Glasberg DS; Santos AMG; Borela ÁM; Pôrto LC
    Transplant Proc; 2018 Apr; 50(3):728-736. PubMed ID: 29661425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
    Wang D; Wu W; Yang S; Wang Q; Tan J
    Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations.
    Matinlauri IH; Kyllönen LE; Salmela KT; Helin H; Pelzl S; Süsal C
    Transplantation; 2005 Dec; 80(12):1809-12. PubMed ID: 16378078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W; Schlaf G; Rothhoff A; Seliger B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.